Skip to content
← Full study record

NCT00325416 · MORE INFO

Limitations, agreements, and source contact

Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma. · Source last updated 2018-03-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Data on presence of chromosomal abnormalities at time of diagnosis were not available for majority of patients. The cancer center will continue to collect information about the participant's disease and its treatment for the rest of their life.
point Of Contact
email
dan.sullivan@moffitt.org
organization
H. Lee Moffitt Cancer Center and Research Institute
phone
813-745-3878
title
Daniel M. Sullivan, M.D.
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Data on presence of chromosomal abnormalities at time of diagnosis were not available for majority of patients. The cancer center will continue to collect information about the participant's disease and its treatment for the rest of their life.
point Of Contact
email
dan.sullivan@moffitt.org
organization
H. Lee Moffitt Cancer Center and Research Institute
phone
813-745-3878
title
Daniel M. Sullivan, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice